Evidence map›Paper›PMID 29025982›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2018

Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.

Thomas A Hope, Emily K Bergsland, Murat Fani Bozkurt, Michael Graham, Anthony P Heaney, Ken Herrmann, James R Howe, Matthew H Kulke, Pamela L Kunz, Josh Mailman and 7 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06611891 (Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer), which is not on this map. Cited by 147 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
147citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06611891 phase3recruitingnot on this mapstarted 2025, after this paper: background citation

Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer

TypeinterventionalSponsorUniversity Hospital, GrenobleRan2025 to 2026Enrolled25ConditionsBreast Cancer MetastaticArms68Ga-DOTATOC
3 · Its place in the literature

Who cites it

147 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
    Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. IncidentalWorld journal of nuclear medicine · 2026
    Article
  10. Review
  11. Article
  12. Optimization of automated radiosynthesis method for [EJNMMI radiopharmacy and chemistry · 2026
    Article
  13. Review
  14. Evaluation of Daughter Radionuclide Release from thePharmaceuticals (Basel, Switzerland) · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

87 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Thomas A HopeSociety of Nuclear Medicine and Molecular Imaging, Reston, Virginia thomas.hope@ucsf.edu.
Emily K BergslandAmerican Society of Clinical Oncology, Alexandria, Virginia.
Murat Fani BozkurtEuropean Association of Nuclear Medicine, Vienna, Austria.
Michael GrahamSociety of Nuclear Medicine and Molecular Imaging, Reston, Virginia.
Anthony P HeaneyEndocrine Society, Washington, DC.
Ken HerrmannEuropean Association of Nuclear Medicine, Vienna, Austria.
James R HoweNorth American Neuroendocrine Tumor Society, Albany, New York.
Matthew H KulkeAmerican Society of Clinical Oncology, Alexandria, Virginia.
Pamela L KunzAmerican Society of Clinical Oncology, Alexandria, Virginia.
Josh MailmanNorCal CarciNET, Ripon, California.
Lawrence MayAmerican College of Physicians, Washington, DC.
David C MetzNorth American Neuroendocrine Tumor Society, Albany, New York.
Corina MilloSociety of Nuclear Medicine and Molecular Imaging, Reston, Virginia.
Sue O'DorisioSociety of Nuclear Medicine and Molecular Imaging, Reston, Virginia.
Diane L Reidy-LagunesAmerican Society of Clinical Oncology, Alexandria, Virginia.
Michael C SoulenNorth American Neuroendocrine Tumor Society, Albany, New York.
Jonathan R StrosbergAmerican Society of Clinical Oncology, Alexandria, Virginia.

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Mark E Burkard · 2000 to 2026
$70.0M
Project 4: New Approaches to Improving the Effectiveness of Radionuclide Targeted Treatments in Neuroendocrine TumorsP50CA174521 · NCI · UNIVERSITY OF IOWA · PI HOWE, JAMES R · 2015 to 2021
$13.2M
NCI NIH HHS P50 CA174521
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Guidelines as TopicPositron-Emission TomographyHumansMultimodal ImagingNeoplasm StagingNeuroendocrine TumorsReceptors, SomatostatinSafetyReceptors, Somatostatin

Identifiers

PMID29025982
PMCPMC6910630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.